RenLite:用于开发全人双抗
RenLite小鼠具有全人抗体重链可变区及固定轻链。用于开发全人双特异性抗体。
海报下载
IO Summit Europe 2024: Fully human conditional agonist 4-1BB×CD40 bispecific antibody exhibits potent in vitro and in vivo efficacy
AACR2024: BCG020, a novel bispecific antibody targeting EGFR and CD70, is effective against EGFR and CD70 high expressed tumors
Advancing Bispecific Antibody Discovery using a Common Light Chain Immunoglobulin Humanized Mouse
相关新闻
云顶国际宣布与杨森达成RenLite授权协议